• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Mackenzie's Mission HomepageMackenzie's Mission

DONATE Mackenzies Mission Donate
  • Mission
  • About
    • The Story
    • Board
  • Resources
    • Resource List
    • What Is Amyloidosis
  • Speakers Bureau
    • About ASB
    • ASB Operating Committee
  • Fundraisers
  • Blog
  • Contact

What Is Amyloidosis

CRISPR/Cas9 – Editing the Code of Life

March 20, 2021

The scientific world is abuzz … a Nobel Prize-winning technology called CRISPR/Cas9 can now edit our DNA. This programmable gene-editing technology, which is efficient, precise, and scalable, has inspired a gold rush of countless applications in medicine, agriculture and basic science.  In this blog we invite you to read more about this ground-breaking advance and how, with one course of treatment, it could potentially cure hereditary transthyretin (hATTR / ATTRv) amyloidosis.

Filed Under: Featured News, What Is Amyloidosis Tagged With: #clinicaltrials, #crispr, #crispr/cas9, amyloidosis, amyloidosis clinical trials, amyloidosis news, amyloidosis treatment, ATTR amyloidosis, attrv, hATTR, Hereditary Amyloidosis, hereditaryamyloidosis

AI, Protein Folding & Amyloidosis

February 18, 2021

AI is rapidly advancing the knowledge of protein misfolding, unlocking answers for amyloidosis which should lead to earlier diagnosis, improved treatment, and better patient survival.

Filed Under: Featured News, What Is Amyloidosis Tagged With: #deepmind, AI, amyloid protein, amyloidosis, amyloidosis diagnosis, amyloidosis news, amyloidosis research, Artificial Intelligence, ATTR amyloidosis, ATTRwt, diagnosing amyloidosis, light chain amyloidosis, Protein Folding, protein misfolding, wild-type amyloidosis

1st FDA-Approved Drug for AL Amyloidosis

January 16, 2021

After decades of relying on treatments approved for other diseases, on January 15, 2021 the FDA approved the first drug for AL Amyloidosis. Truly a game-changing, monumental advancement in the treatment of this disease.

Filed Under: Featured News, What Is Amyloidosis Tagged With: #Andromeda, AL amyloidosis, amyloidosis, amyloidosis clinical trials, amyloidosis news, amyloidosis treatment

Not Just A Game: Protein Structure Prediction

January 10, 2021

One of the greatest biological challenges science has faced is predicting the shape of proteins from its component amino acids. With the number of possible configurations estimated to be 10 to the power of 300, the answers seemed unreachable. Until now.

Filed Under: Featured News, What Is Amyloidosis Tagged With: #alphafold, #alphago, #deepmind, #foldedprotein, #humangenomeproject, #proteinfolding, #proteinstructureprediction, #proteinstructurepredictor, amyloidosis

Spinal Stenosis & Amyloidosis

November 10, 2020

Spinal stenosis can be one of those precursor clues to amyloidosis, particularly senile, aka wild-type, amyloidosis (ATTRwt).

Filed Under: Featured News, What Is Amyloidosis Tagged With: amyloidosis, amyloidosis diagnosis, ATTR amyloidosis, ATTRwt, cardiac amyloidosis, lumbar stenosis, spinal stenosis, stenosis, wild-type amyloidosis

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 6
  • Go to Next Page »

Primary Sidebar

Recent News

  • CRISPR/Cas9 – Editing the Code of Life
  • Charolotte Raymond
  • AI, Protein Folding & Amyloidosis
  • Comfort & Connection
  • On the Other Side of COVID

Be A Part Of Our Mission!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

  • Mission
  • About
  • Resources
  • Speakers Bureau
  • Fundraisers
  • Blog
  • Contact

Registered 501(c)(3) · Contact · Copyright © 2021 · Mackenzies Mission - All Rights Reserved